Published on 01 February 2017
Effective generics substitution
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2017.0602.019
5.090 views
Published on 01 February 2017
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2017.0602.019
5.090 views
Published on 23 January 2017
Author(s): GaBI Journal Editor
biological, biosimilar, patent
DOI: 10.5639/gabij.2017.0601.006
26.930 views
Published on 23 January 2017
Author(s): Anu Gore, PhD, Chetan Pujara, PhD, Mayssa Attar, PhD, Sesha Neervannan, PhD
dry eye, ocular, ophthalmic, safety, topical
DOI: 10.5639/gabij.2017.0601.004
17.826 views
Published on 04 January 2017
2.928 views
Published on 16 December 2016
Author(s): GaBI Journal Editor
biosimilar, biosimiliarity, data requirements, extrapolation
DOI: 10.5639/gabij.2016.0504.047
6.647 views
Published on 16 December 2016
Author(s): Professor Philip D Walson, MD
DOI: 10.5639/gabij.2016.0504.038
3.810 views
Published on 14 December 2016
Author(s): GaBI Journal Editor
biosimilar, labelling, patients, pharmacists, physicians, Summary of Product Characteristics (SmPC)
DOI: 10.5639/gabij.2017.0601.008
9.362 views
Published on 14 December 2016
Author(s): Associate Professor Martine Lamfers, PhD, Professor Arnold G Vulto, PharmD, PhD, FCP, Professor Sieger Leenstra, MD, PhD, Subramanian Venkatesan, MSc
anticancer drugs, kinase inhibitors, market exclusivity, patent expiry, targeted therapies
DOI: 10.5639/gabij.2017.0602.016
59.517 views
Published on 14 December 2016
Author(s): Barbara OM Claus, PharmD, PhD, Professor Annemie Somers, PharmD, PhD, Tiene Bauters, PharmD, PhD
biologicals, biosimilars, hospitals, pharmacovigilance
DOI: 10.5639/gabij.2017.0601.005
8.129 views
Published on 14 December 2016
Author(s): Harry L Gewanter, MD, FAAP, FACR, Michael S Reilly, Esq
ASBM, biosimilar, interchangeability, labelling, legislation, naming
DOI: 10.5639/gabij.2017.0601.003
10.378 views
Published on 14 December 2016
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2016.0504.050
4.082 views
Published on 12 December 2016
Author(s): Emmanuelle Charton, PhD
biotherapeutic products, complexity of biologicals, monographs, pharmacopoeia, public standards
DOI: 10.5639/gabij.2016.0504.045
20.263 views